FMF Connect App Improves Caregiver Outcomes

This randomized controlled trial (N=129) tested the FMF Connect self-directed mHealth app for caregivers of children aged 3–12 with FASD or prenatal alcohol exposure, conducted in the United States with 12-week follow-up. Relative to waitlist, app users showed greater improvements in FASD knowledge, caregiver behavior attributions, family needs met, and self-care, with small-to-medium effect sizes and 64% retention.
Key Points
- 1Demonstrates efficacy: FMF Connect improved FASD knowledge, caregiver attributions, family needs met, and self-care.
- 2Indicates significance: small-to-medium effect sizes suggest meaningful caregiver-level changes over 12 weeks.
- 3Supports scalability: self-directed mHealth delivery can expand access to evidence-based FASD caregiver supports.
Scoring Rationale
Strong RCT evidence and peer-reviewed publication support findings, but modest sample size and condition-specific scope limit generalizability.
Sources
Public references used for this report.
Practice with real Health & Insurance data
90 SQL & Python problems · 15 industry datasets
250 free problems · No credit card
See all Health & Insurance problems
